Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Martine Meyer, Consultant in Palliative Medicine Epsom & St Helier University Hospitals NHS Trust
Send response to journal:
|
COMMENTS: I am in complete agreement with Nick C Bradley (GP) who wrote (letters: 12 July) to suggest that the BMJ publish regular reports about 'Pharmaceutical-driven Research Offering Specious Evidence' (PROSE). As evidenced by the recent BMJ issue, dedicated entirely to the somewhat uncomfortable and ambivalent relationship that we professionals have with the pharmaceutical companies - it behoves the BMJ to be pro-active in providing clear, concise, unbiased, evidence-based information about current drugs (particularly the new and very expensive 'copycats') and their relative clinical effectiveness. POEM (Patient-Oriented Evidence that Matters) has proved to be a very useful and effective way of communicating clinical information relevant to our daily work, and I am sure that PROSE would be similarly welcomed. I do hope that the BMJ will consider Dr Bradley's suggestion seriously, and take it forward. Competing interests: None declared |
|||